ArriVent BioPharma, Inc. — SCHEDULE 13G Filings
6 SCHEDULE 13G filings on record
This page lists all SCHEDULE 13G filings submitted to the SEC by ArriVent BioPharma, Inc. (AVBP), sorted by most recent first. Each row links to the full filing on EdgarLookup. ArriVent BioPharma, Inc. has filed 6 SCHEDULE 13G documents with the SEC since 2021. To view all SEC filings by ArriVent BioPharma, Inc., see the full filings list.
All
10-K
10-Q
3
4
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13G
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0002012383-26-000643 | Jan 21, 2026 | — |
| SCHEDULE 13G | — | 0000102909-25-000025 | Oct 30, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-099728 | Oct 15, 2025 | — |
| SCHEDULE 13G | — | 0002058093-25-000008 | Aug 13, 2025 | — |
| SCHEDULE 13G | — | 0002058093-25-000002 | May 15, 2025 | — |
| SCHEDULE 13G | — | 0000950170-25-021707 | Feb 14, 2025 | — |